Correlation Engine 2.0
Clear Search sequence regions

  • diagnosis (6)
  • EPCAM (1)
  • germ line (1)
  • humans (1)
  • mismatch repair (2)
  • MLH1 (1)
  • MSH2 (1)
  • MSH6 (2)
  • probands (10)
  • Sizes of these terms reflect their relevance to your search.

    Objective Little is known about the time from developing a first cancer to confirming the presence of a mismatch repair (MMR) gene mutation for Lynch syndrome (LS) probands. Methods This was a retrospective single center study. LS probands, who have an MMR gene mutation that was confirmed first in a pedigree and thereafter developed at least one cancer, were included in this study. Results There were 21 LS probands who had developed at least one cancer; 6 with MLH1 mutations, 9 with MSH2 mutations, 4 with MSH6 mutations, and 2 with EPCAM deletions. The median ages at the first cancer and the genetic diagnosis were 47 (34-71) and 62 (38-84) years old, respectively. The mean interval between the first cancer and the genetic diagnosis was 11.0 (0-25) years, and 20 years or longer interval was required for the 5 probands. Six (28.6%) probands were older than 70 years, and 3 (14.3%) were in their 80s when they were diagnosed to have LS. The genetic diagnosis was confirmed at the first, second, third, and fourth cancer or later in 5, 5, 6, and 5 probands, respectively. Of the 16 cancers examined, 2 (12.5%) were microsatellite stable (MSS), both of whom had germline MSH6 mutations. All 17 LS probands who developed colorectal cancer met the revised Bethesda guidelines at the genetic diagnosis, but only 7 of 11 (63.6%) met them at the first cancer. Twelve out of 21 (57.1%) met the revised Amsterdam criteria. Conclusion It took 11 years for the LS probands from the first cancer to the diagnostic confirmation by genetic tests. A quarter of the probands were in their 70s or 80s at genetic diagnosis.


    Kentaro Yamashita, Hisayo Fukushima, Mizue Teramoto, Kenji Okita, Aki Ishikawa, Akihiro Sakurai, Kiwamu Akagi, Hiroshi Nakase. Interval between the First Cancer and the Genetic Diagnosis in Lynch Syndrome Probands. Internal medicine (Tokyo, Japan). 2021 Sep 01;60(17):2719-2724

    Expand section icon Mesh Tags

    PMID: 33746161

    View Full Text